Table 2

Demographics, season of inclusion, treatment and outcome

GroupsARIControlP value
Total inclusions (N)349306
Sex (male, n, %)202 (57.9)200 (65.4)<0.001
Age in years (median, IQR)1.09 (0.42 to 2.49)1.80 (0.93 to 3.65)<0.001
Age range (n, %)
 <12 months160 (45.9)83 (27.1)<0.001
 12–<36 months120 (34.4)114 (37.3)
 ≥36 months69 (19.8)109 (35.6)
Inclusion by season (n, %)
 October–December76 (21.8)85 (27.8)<0.001
 January–March182 (52.2)115 (37.6)
 April–September91 (26.1)106 (34.6)
Inclusion by country (n, %)
 Greece144 (41.3)50 (16.3)<0.001
 Italy85 (24.4)46 (15.0)
 Spain45 (12.9)45 (14.7)
 UK55 (15.8)94 (30.7)
 Other20 (5.7)71 (23.2)
Symptom onset prior to inclusion in days (median, IQR)2 (1 to 4)
IVF during inpatient stay (n, %)184 (52.7)
Antibiotic treatment (n, %)207 (59.3)
PICU admission9 (2.6)
Length of hospital stay in days (median, IQR)3 (2 to 5)
Clinician diagnosis at discharge
 URTI69 (19.8)
 LRTI245 (70.2)
 Unspecified35 (10.0)
Died (n, %)0 (0.0)
  • P values were obtained using χ2 test or Wilcoxon rank-sum test as applicable.

  • ARI, acute respiratory infection; IQR, interquartile range; IVF, intravenous fluid; LRTI, lower respiratory tract infection; PICU, paediatric intensive care unit; URTI, upper respiratory tract infection.